Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M27,574Revenue (TTM) $M2,954Net Margin (%)12.5Altman Z-Score4.0
Enterprise Value $M29,737EPS (TTM) $1.6Operating Margin %21.6Piotroski F-Score6
P/E(ttm)75.0Beneish M-Score-2.4Pre-tax Margin (%)18.5Higher ROA y-yN
Price/Book3.210-y EBITDA Growth Rate %--Quick Ratio2.7Cash flow > EarningsY
Price/Sales9.35-y EBITDA Growth Rate %35.4Current Ratio3.1Lower Leverage y-yY
Price/Free Cash Flow70.1y-y EBITDA Growth Rate %26.5ROA % (ttm)2.8Higher Current Ratio y-yN
Dividend Yield %--PEG2.1ROE % (ttm)4.5Less Shares Outstanding y-yY
Payout Ratio %--Shares Outstanding M224ROIC % (ttm)4.1Gross Margin Increase y-yY

Gurus Latest Trades with ALXN

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
ALXNJohn Paulson 2016-09-30 Reduce-0.05%$117.64 - $137.66
($128.72)
$ 122.01-5%Reduce -15.04%227,700
ALXNJoel Greenblatt 2016-09-30 Reduce-0.02%$117.64 - $137.66
($128.72)
$ 122.01-5%Reduce -19.95%46,797
ALXNRon Baron 2016-09-30 Reduce-0.01%$117.64 - $137.66
($128.72)
$ 122.01-5%Reduce -28.90%44,260
ALXNJohn Paulson 2016-06-30 Add0.14%$111.89 - $161.38
($141.84)
$ 122.01-14%Add 70.48%268,000
ALXNJoel Greenblatt 2016-06-30 Add0.07%$111.89 - $161.38
($141.84)
$ 122.01-14%Add 447.16%58,459
ALXNRon Baron 2016-06-30 Add$111.89 - $161.38
($141.84)
$ 122.01-14%Add 11.26%62,249
ALXNDodge & Cox 2016-06-30 Sold Out $111.89 - $161.38
($141.84)
$ 122.01-14%Sold Out0
ALXNJohn Paulson 2016-03-31 Buy 0.17%$127.91 - $190.75
($147.61)
$ 122.01-17%New holding157,200
ALXNJoel Greenblatt 2016-03-31 Buy 0.02%$127.91 - $190.75
($147.61)
$ 122.01-17%New holding10,684
ALXNDodge & Cox 2016-03-31 Buy $127.91 - $190.75
($147.61)
$ 122.01-17%New holding1,820
ALXNRon Baron 2016-03-31 Reduce$127.91 - $190.75
($147.61)
$ 122.01-17%Reduce -8.54%55,950
ALXNRon Baron 2015-12-31 Add0.02%$152.66 - $191.88
($175.28)
$ 122.01-30%Add 87.52%61,177
ALXNDavid Swensen 2015-09-30 Sold Out -16.37%$145.6 - $207.84
($182.41)
$ 122.01-33%Sold Out0
ALXNRon Baron 2015-09-30 Reduce-0.03%$145.6 - $207.84
($182.41)
$ 122.01-33%Reduce -53.24%32,624
ALXNMario Gabelli 2015-09-30 Sold Out $145.6 - $207.84
($182.41)
$ 122.01-33%Sold Out0
ALXNDavid Swensen 2015-06-30 Buy 16.37%$155.01 - $190.92
($172.58)
$ 122.01-29%New holding319,273
ALXNJoel Greenblatt 2015-06-30 Sold Out -0.03%$155.01 - $190.92
($172.58)
$ 122.01-29%Sold Out0
ALXNRon Baron 2015-06-30 Add0.02%$155.01 - $190.92
($172.58)
$ 122.01-29%Add 69.48%69,764
ALXNMario Gabelli 2015-06-30 Buy $155.01 - $190.92
($172.58)
$ 122.01-29%New holding1,415
ALXNJoel Greenblatt 2015-03-31 Reduce-0.09%$171.42 - $189.07
($181.01)
$ 122.01-33%Reduce -72.94%23,261
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ALXN is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


ALXN: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Wagner Heidi LSVP, Global Government Affairs 2016-11-14Sell59$115.16view
BELL LEONARDDirector 2016-11-04Sell37,317$140.38-13.09view
BELL LEONARDDirector 2016-10-31Sell1,634$135.3-9.82view
Thiel CarstenEVP, Chief Commercial Officer 2016-10-14Sell4,584$120.281.44view
Thiel CarstenEVP, Chief Commercial Officer 2016-10-03Sell29$122.41-0.33view
Wagner Heidi LSVP, Global Government Affairs 2016-10-03Sell120$122.41-0.33view
Thiel CarstenEVP, Chief Commercial Officer 2016-09-13Sell3,225$128.67-5.18view
Miller EdwardSVP, Chief Compliance Officer 2016-09-09Sell367$128.32-4.92view
Thiel CarstenEVP, Chief Commercial Officer 2016-09-06Sell1,000$125.94-3.12view
O'Neill JulieEVP. Global Operations 2016-09-02Sell650$126.29-3.39view

Quarterly/Annual Reports about ALXN:

News about ALXN:

Articles On GuruFocus.com
Spiros Segalas on Alexion Pharmaceuticals Aug 18 2016 
Spiros 'Sig' Segalas' Capital Appreciation Fund 2nd Quarter Commentary Nov 07 2016 
Frank Sands Sells Visa, Baidu, Alibaba May 24 2016 
Baron Funds Comments on Alexion Pharmaceuticals May 23 2016 
Baron Funds Comments on Alexion Pharmaceuticals May 23 2016 
Baron Funds Comments on Alexion Pharmaceuticals May 06 2016 
Baron Funds Comments on Alexion Pharmaceuticals Feb 08 2016 
Weekly CFO Sales Highlight: H&R Block, DISH Network, Alexion Pharmaceuticals Jan 03 2016 
Weekly CFO Sells Highlight: Tyson Foods, Alexion Pharmaceuticals, Gilead Sciences Dec 13 2015 
Weekly Insider Sells Highlights: CDW, Twitter, P&G, Alexion Pharmaceuticals Dec 10 2015 

More From Other Websites
2:22 am Alexion Pharma presents new data from ALXN1210 dose-escalation study; recruitment under way... Dec 05 2016
New Data from ALXN1210 Dose-Escalation Study Presented at ASH Show Rapid and Sustained Reductions in... Dec 04 2016
INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Alexion... Dec 02 2016
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in... Dec 02 2016
SHAREHOLDER NOTICE: Lundin Law PC Announces Securities Class Action Lawsuit against Alexion... Dec 01 2016
Is Alexion Pharmaceuticals, Inc. (ALXN) a Good Stock To Buy? Dec 01 2016
Lifshitz & Miller Law Firm Announces Investigation of Alexion Pharmaceuticals, Inc., Blue Nile,... Dec 01 2016
ETFs with exposure to Alexion Pharmaceuticals, Inc. : December 1, 2016 Dec 01 2016
SHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Alexion... Nov 30 2016
INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Alexion Pharmaceuticals, Inc. of a... Nov 30 2016
Alexion Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : ALXN-US :... Nov 30 2016
U.S. Stocks Edge Higher, Led by Health-Care Gains Nov 30 2016
The Hot Stock: Alexion Pharmaceuticals Jumps 5.2% Nov 29 2016
Healthcare Stocks Help Nasdaq Reach New Heights Nov 29 2016
Stocks Subdued by Lower Commodities Prices Nov 29 2016
INVESTOR NOTICE: Lundin Law PC Announces Securities Class Action Lawsuit against Alexion... Nov 29 2016
SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against... Nov 29 2016
Alexion to Present at the Citi 2016 Global Healthcare Conference Nov 29 2016
Lawsuit for Investors in Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) shares announced by... Nov 29 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)